Guerbet

GBTFR0000032526

Guerbet is a France-based manufacturer of contrast agents used in medical imaging. The company was founded in 1926 by André Guerbet, the son of Marcel Guerbet who in 1901 discovered Lipiodol – the first iodinated X-ray contrast agent.

Filings

23 filings

All Inside information23 Voting rights and capital18 Earnings release14 Share buyback7 Universal registration document5 Corporate governance4 Half-year financial report1 Threshold crossing1

22/05/2026
Guerbet: Changes to the Composition of Guerbet’s Board of Directors.
Inside informationFR
11/03/2026
GUERBET : Change in Guerbet’s Board of Directors.
Inside informationFR
02/12/2025
GUERBET : Adjustment of 2025 financial targets.
Inside information
19/11/2025
GUERBET : Financial agenda for 2026
Inside information
22/09/2025
Guerbet : Change in General Management
Inside informationFR
15/09/2025
Guerbet : Adjustment of 2025 full-year financial targets
Inside informationFR
29/08/2025
Évolutions au sein du Comité exécutif
Inside informationFrench
26/05/2025
Guerbet : Changes in the composition of the Guerbet board of directors.
Inside informationFR
24/04/2025
Guerbet: Q1 2025 revenue
Inside informationFR
18/03/2025
DUOncoTM Bone : First CE marked IA algorithm for automatic detection of bone lesions on CT scan.
Inside informationFR
06/02/2025
GUERBET : 2024 revenue.
Inside informationFR
31/01/2025
Correction: GUERBET : Financial agenda for 2025
Inside informationFR
13/01/2025
Correction: GUERBET : Financial agenda for 2025
Inside informationFR

About

ISIN: FR0000032526
Ticker: GBT
LEI: 969500WV1U1WQ059L135
Founded: 1926
Country of registration: FR
Last filing: 23/07/2026, 17:45

Wikipedia

Description from Wikidata, CC0 licence.

Filing history

Filings per month

Sept 23May 24Jan 25Sept 25Aug 26

Document types

Across the whole archive